Diosgenin Exerts Antitumor Activity via Downregulation of Skp2 in Breast Cancer Cells
Diosgenin Exerts Antitumor Activity via Downregulation of Skp2 in Breast Cancer Cells
About this item
Full title
Author / Creator
Publisher
United States: Hindawi
Journal title
Language
English
Formats
Publication information
Publisher
United States: Hindawi
Subjects
More information
Scope and Contents
Contents
Background. Breast cancer is the common malignancy with high morbidity and mortality in women. S-phase kinase-associated protein 2 (Skp2) has been characterized to play an oncogenic role in the breast carcinogenesis and progression. Therefore, inactivation of Skp2 in breast cancer might be a novel approach for fighting breast malignancy. A natural...
Alternative Titles
Full title
Diosgenin Exerts Antitumor Activity via Downregulation of Skp2 in Breast Cancer Cells
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7317312
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7317312
Other Identifiers
ISSN
2314-6133
E-ISSN
2314-6141
DOI
10.1155/2020/8072639